scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00418-010-0747-1 |
P698 | PubMed publication ID | 20886225 |
P50 | author | Seddik Hammad | Q42872147 |
Jan G Hengstler | Q49800573 | ||
P2093 | author name string | Patricio Godoy | |
Dirk Drasdo | |||
Albert Braeuning | |||
Michael Schwarz | |||
Albrecht Buchmann | |||
Stefan Hoehme | |||
Benjamin Rignall | |||
Yasmin Singh | |||
Amnah Othman | |||
Iris von Recklinghausen | |||
P2860 | cites work | A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 |
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin | Q28190343 | ||
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver | Q28589915 | ||
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas | Q28592004 | ||
Hepatocellular carcinoma pathogenesis: from genes to environment | Q29615767 | ||
Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration | Q30495068 | ||
Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. | Q31443692 | ||
Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis | Q35197463 | ||
Metabolic zonation of the liver: regulation and implications for liver function | Q35417325 | ||
Focus on hepatocellular carcinoma. | Q35721877 | ||
Evidence that interaction of hepatocytes with the collecting (hepatic) veins triggers position-specific transcription of the glutamine synthetase and ornithine aminotransferase genes in the mouse liver | Q36743544 | ||
WNT/beta-catenin signaling in liver health and disease | Q36804161 | ||
Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved. | Q36892230 | ||
Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. | Q37298654 | ||
beta-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver | Q37661567 | ||
Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver | Q38346810 | ||
Functional specialization of different hepatocyte populations | Q38663205 | ||
The RL-ET-14 cell line mediates expression of glutamine synthetase through the upstream enhancer/promoter region. | Q40426377 | ||
Zonation of metabolism and gene expression in liver. | Q40459673 | ||
Glutamine synthetase and hepatocarcinogenesis | Q40459807 | ||
Zonation of parenchymal and nonparenchymal metabolism in liver | Q41138372 | ||
Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver | Q41333879 | ||
Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. | Q41449098 | ||
Cell-cell interactions in the regulation of the expression of hepatic enzymes. | Q41594522 | ||
Zonation of hepatic cytochrome P-450 expression and regulation | Q41665962 | ||
Induction of glutamine synthetase in periportal hepatocytes by cocultivation with a liver epithelial cell line | Q41720553 | ||
Beta-catenin: a key mediator of Wnt signaling | Q41732761 | ||
Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. | Q42067728 | ||
Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. | Q42449884 | ||
Conditional deletion of beta-catenin reveals its role in liver growth and regeneration | Q42504022 | ||
Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors | Q43831008 | ||
Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. | Q44183092 | ||
New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism | Q44226601 | ||
A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors | Q45096299 | ||
Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice | Q46224632 | ||
Tumor promotion in liver of mice with a conditional Cx26 knockout | Q46727133 | ||
Zonal gene expression in murine liver: lessons from tumors | Q46959089 | ||
Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. | Q48906218 | ||
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis. | Q51775502 | ||
Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. | Q51990803 | ||
Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. | Q53391138 | ||
Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations | Q64379604 | ||
Reestablishment of the heterogeneous distribution of hepatic glutamine synthetase during regeneration after CCl4-intoxication | Q68090097 | ||
Periportal and perivenous hepatocytes retain their zonal characteristics in primary culture | Q70150169 | ||
Position-specific gene expression in the liver lobule is directed by the microenvironment and not by the previous cell differentiation state | Q77801036 | ||
Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas | Q79551069 | ||
Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy | Q79671125 | ||
PCB 153, a non-dioxin-like tumor promoter, selects for beta-catenin (Catnb)-mutated mouse liver tumors | Q79748085 | ||
Zonal expression of hepatocytic marker enzymes during liver repopulation | Q80494884 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 469-481 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Histochemistry and Cell Biology | Q1524012 |
P1476 | title | Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice | |
P478 | volume | 134 |
Q46907265 | A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl4-induced pseudolobules is a portal vein |
Q41777442 | A novel role of nucleostemin in maintaining the genome integrity of dividing hepatocytes during mouse liver development and regeneration |
Q39336968 | Advances in 2D and 3D in vitro systems for hepatotoxicity testing |
Q90641023 | Amniotic mesenchymal stem cells derived hepatocyte-like cells attenuated liver fibrosis more efficiently by mixed-cell transplantation |
Q46166158 | Creation of Three-Dimensional Liver Tissue Models from Experimental Images for Systems Medicine. |
Q35546735 | Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development |
Q42731617 | Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation. |
Q41870215 | Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas |
Q46359928 | Hepatocellular cancer |
Q39297334 | Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions |
Q41774035 | Highlight report: Software for tissue analysis and reconstruction. |
Q37833524 | Histochemistry and cell biology: the annual review 2010. |
Q52853229 | Is the question of phenobarbital as potential liver cancer risk factor for humans really resolved? |
Q39356585 | Pericentral activity of alpha-fetoprotein enhancer 3 and glutamine synthetase upstream enhancer in the adult liver are regulated by β-catenin in mice. |
Q46889611 | Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. |
Q84711004 | Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice |
Q30442295 | Postnatal development, maturation and aging in the mouse cochlea and their effects on hair cell regeneration |
Q37717919 | Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis |
Q41966844 | Quantification of three-dimensional structures in liver tissue: bile canalicular and sinusoidal networks |
Q37121662 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. |
Q44039549 | Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen |
Q38879910 | Signal integration by the CYP1A1 promoter--a quantitative study |
Q38601609 | Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury |
Q42837606 | Tumor formation in liver of conditional -catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen |
Q40030443 | Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice |
Q91643281 | Wnt signaling in liver disease: emerging trends from a bibliometric perspective |
Search more.